Guidance

National protocol for COVID-19 mRNA vaccine (5 to 17 years of age)

Protocol for the administration of COVID-19 mRNA vaccine to individuals aged 5 to 17 years in accordance with the national COVID-19 vaccination programme.

From:
UK Health Security Agency
Published
3 April 2023
Last updated
2 April 2024 — See all updates

Applies to England

Documents

National protocol for COVID-19 mRNA vaccine (5 to 17 years of age)

Ref: UKHSA gateway number GOV-16168

MS Word Document, 169 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This protocol is for the administration of COVID-19 mRNA vaccine to children and young people aged 5 to 17 years in accordance with the national COVID-19 vaccination programme by appropriately trained persons.

National protocol for COVID-19 mRNA vaccine (5 to 17 years of age) version 4.00 is valid from 8 April 2024 to 30 June 2024.

The corresponding COVID-19 PGD for use in individuals aged 5 to 17 years will be available at NHS England.

Published 3 April 2023
Last updated 2 April 2024 + show all updates

  1. Added version 4 – see page 3 for change history.

  2. Added version 3 – see page 3 for change history.

  3. Added version 02.00 – see page 3 for change history.

  4. First published.

Related content